Adam Friedman

Papers

Total Citations

H-Index

About

Adam Friedman is a leading clinical researcher in anesthesiology and perioperative medicine, with a focused expertise in regional anesthesia and enhanced recovery after surgery (ERAS) protocols. His work centers on optimizing pain management strategies for minimally invasive thoracic surgery, particularly through comparative effectiveness trials of nerve block techniques. In his landmark 2024 randomized clinical trial, Friedman directly compared liposomal bupivacaine against standard bupivacaine with dexamethasone for intercostal nerve blocks in robotic thoracic surgery, providing crucial evidence on postoperative pain outcomes. This study, already garnering 3 citations shortly after publication, has helped refine clinical guidelines for multimodal analgesia. Beyond this, his research portfolio demonstrates a commitment to translating pharmacological innovations into practical, evidence-based protocols that reduce opioid consumption and accelerate recovery. Friedman’s contributions are shaping how anesthesiologists approach peripheral nerve blocks, making him a key voice in the ongoing evolution of pain management in thoracic surgery. His work is essential reading for clinicians and researchers seeking to balance efficacy, safety, and cost-effectiveness in regional anesthesia.